A Phase III Study to Evaluate the Efficacy and Safety of AK120 in Patients With Moderate to Severe Atopic Dermatitis
Clinical trial NCT06383468 · UNKNOWN
Trial details
- NCT number
- NCT06383468
- Sponsor
- Akeso
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-04-30
- Primary completion
- 2025-01-30
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.